XYTS
XYTOS (the "Company") (OTC: XYTS) is excited to announce their Cancer Diagnostic Fluorescent Scanning Technique.
The XYTOS procedure is a major achievement in the fight against cancer. XYTOS expects that their fluorescent scanning technique will soon become the standard for diagnosing Breast and Skin Cancer. XYTOS is able to illuminate cancer cells years before the cancer would be detectable by current diagnostic procedures such as the mammogram. This early diagnostic technique allows XYTOS to fight cancer at the very earliest stages, before a lump can develop. Fluorescent Scanning works best on Breast and Skin Cancer because the cancer is near the surface of the body. XYTOS Fluorescent Scanning has the ability to detect cancer at its earliest stages well before it becomes a tumor. At present, the mammogram is the accepted diagnostic tool for detecting breast cancer. From day one through 3 years cancer is undetectable using a mammogram. Cancer cells could possibly be present 3 years before they are detectable by a mammogram, and by the time the cancer is detected by mammogram in the form of a lump/tumor the cancer has been present for 6 plus years. In time XYTOS expects their fluorescent scanning technique to become the standard for diagnosing Breast and Skin Cancer.
Tim Cook, Chairman and CEO of XYTOS, Inc., commented, “We are truly excited about this new innovative and non-invasive cancer diagnostic technique for detecting surface and near surface cancerous tumors. After taking XyChloro® sublingually, XyChloro® will fluoresce at a specific wavelength as the body is scanned with a laser. Fluorescent radiation from XyChloro® activated inside the tumors is detected with a camera fitted with a filter and displayed on a TV screen or computer. Cancer shows up as fluorescent areas of various shapes and sizes. The fluorescence’s is in the form of a bright white spot under the skin. Pictures of how the cancer looks when scanned can be seen on our website at www.xytos.com. Additionally readers can cut and paste the following link to see a short video of a XYTOS patient undergoing Fluorescent Scanning Diagnostics (xytos.com/fsp.mov). Note that the patient is resting comfortably during the procedure. Further, although it takes a trained professional to interpret the full results of the procedure, the viewer will clearly see a bright white spot under the patient's left eye, which is cancerous. Finally it is important to understand that fluorescent scanning works best on surface and near surface cancers, namely breast and skin. With deeper tumors we must rely on more conventional diagnostic techniques at this time.”
XYTOS, working at the forefront of the "Science of Medicine," is a Bio-Medical Technology Company concentrating on the research, development, and introduction of Next Generation Medicine and Medical Procedures in the areas of Stem Cell Therapies, Tissue Engineering, Cellular Medicine, and Cancer.
